EA200970325A1 - [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENZIL] TRIMETYLAMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS - Google Patents

[2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENZIL] TRIMETYLAMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS

Info

Publication number
EA200970325A1
EA200970325A1 EA200970325A EA200970325A EA200970325A1 EA 200970325 A1 EA200970325 A1 EA 200970325A1 EA 200970325 A EA200970325 A EA 200970325A EA 200970325 A EA200970325 A EA 200970325A EA 200970325 A1 EA200970325 A1 EA 200970325A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indol
treatment
ilsulfanil
trimetylamine
benzil
Prior art date
Application number
EA200970325A
Other languages
Russian (ru)
Inventor
Ян Келер
Карстен Юль
Нейл Андерсон
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2007/000419 external-priority patent/WO2008037258A1/en
Publication of EA200970325A1 publication Critical patent/EA200970325A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Предложен [2-(6-фтор-1Н-индол-3-илсульфанил)бензил]метиламин и его фармацевтически приемлемые соли, при условии, что указанное соединение не является свободным основанием в некристаллической форме, для лечения аффективных расстройств.Proposed [2- (6-fluoro-1H-indol-3-ylsulfanyl) benzyl] methylamine and its pharmaceutically acceptable salts, provided that said compound is not a free base in a non-crystalline form, for the treatment of affective disorders.

EA200970325A 2006-09-28 2007-09-27 [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENZIL] TRIMETYLAMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS EA200970325A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601251 2006-09-28
DKPA200700432 2007-03-20
PCT/DK2007/000419 WO2008037258A1 (en) 2006-09-28 2007-09-27 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

Publications (1)

Publication Number Publication Date
EA200970325A1 true EA200970325A1 (en) 2009-12-30

Family

ID=40225153

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970325A EA200970325A1 (en) 2006-09-28 2007-09-27 [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENZIL] TRIMETYLAMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS

Country Status (8)

Country Link
KR (1) KR20090074749A (en)
AR (1) AR062981A1 (en)
BR (1) BRPI0717038A2 (en)
CL (1) CL2007002789A1 (en)
EA (1) EA200970325A1 (en)
IL (1) IL197720A0 (en)
NO (1) NO20091642L (en)
TW (1) TW200829550A (en)

Also Published As

Publication number Publication date
KR20090074749A (en) 2009-07-07
BRPI0717038A2 (en) 2013-10-01
NO20091642L (en) 2009-04-27
AR062981A1 (en) 2008-12-17
TW200829550A (en) 2008-07-16
CL2007002789A1 (en) 2008-04-18
IL197720A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
EA200801826A1 (en) DEUTERATED CATECHOLAMINE DERIVATIVES AND MEDICINES CONTAINING INDICATED COMPOUNDS
MX2010009268A (en) Compounds that are erk inhibitors.
EA200800147A1 (en) METHOD OF OBTAINING OLMESARTAN MEDOKSOMIL
BRPI0517438A (en) compound, method for treating the condition associated with muscarinic m4 receptor activity, compound use, and, pharmaceutical composition
MX2009000001A (en) Therapeutic compounds.
SE0401342D0 (en) Therapeutic compounds
AR061446A1 (en) USE OF 1,7-DIMETHYLXANTINE FOR THE MANUFACTURE OF A NON-ANIOIOUS PSYCHOANALEPTIC DRUG FOR THE TREATMENT OF A NEUROPSYCHIATRIC DISORDER
NZ577392A (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
MX2010003989A (en) Composition 064.
EA200602180A1 (en) DERIVATIVES OF 2- (1H-INDOLYLSULPHANIL) ARYLAMINE TO BE USED FOR THE TREATMENT OF AFFECTIVE DISORDERS, PAIN, NGDV, AND STRESS UDERSTANDATION
BRPI0417858A (en) compound, pharmaceutical composition, and use of a pharmaceutical composition
SE0401465D0 (en) New substituted piperdines as modulators of dopamine neurotransmission
RU2007122391A (en) S-MIRTAZAPINE FOR TIDAL TREATMENT
RU2007121516A (en) TREATMENT OF MASTITIS USING ENROFLOXACIN
ATE488236T1 (en) COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS
CY1112718T1 (en) N- (2-Hydroxyethyl) -N-Methyl-4- (quinolin-8-yl (1- (thiazole-4-ylmethyl) piperidin-4-ylideno) methyl) benzamide THE THERAPEUTIC TREATMENT OF PAIN, ANXIETY AND DEPRESSION
EA200702201A1 (en) ROFLUMILAST FOR TREATMENT OF PULMONARY HYPERTENSION
MX2009003299A (en) [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders.
EA200600898A1 (en) NEW METHOD OF SYNTHESIS PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
CL2010001471A1 (en) A 2-fluoro-11- (piperazin-1.il) dibenzo'1,4 thiazepine compounds, net inhibitors and moderate d2 antagonist; preparation procedure thereof; pharmaceutical composition; and use in the treatment of psychiatric disorders, among other diseases ..
ITMI20040954A1 (en) DERIVATIVES OF 3,6-DIAZABICICLO 3.1.I. HEPTANE WITH ANALGESIC ACTIVITY
EA200970325A1 (en) [2- (6-FLUOR-1H-INDOL-3-ILSULFANIL) BENZIL] TRIMETYLAMINE FOR THE TREATMENT OF AFFECTIVE DISORDERS
RS51676B (en) Use of agomelatine to obtain medication aimed at treating smith-magenis syndrome
UY29470A1 (en) USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS
DE60300683D1 (en) Prucalopride NOXIDE